ESC Premium Access

Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity

Congress Session

About the speaker

Doctor Lars Michel

University of Duisburg-Essen, West German Heart and Vascular Center, Essen (Germany)
0 follower

5 more presentations in this session

Echocardiography for the 10-year prediction of cardiomyopathy in long-term survivors of childhood cancer

Speaker: Mr J. Leerink (Amsterdam, NL)

Thumbnail

Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways

Speaker: Doctor V. Quagliariello (Naples, IT)

Thumbnail

Tamponade during immune checkpoint inhibitors therapy in lung cancer: case-reports and systematic review of the literature

Speaker: Doctor H. Mustafic (Clamart, FR)

Thumbnail

SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin 6 axis and mTORC1 /Fox01/3a mediated apoptosis

Speaker: Doctor V. Quagliariello (Naples, IT)

Thumbnail

Cardiovascular risk factors during cancer treatment: prevalence, incidence and prognostic relevance.

Speaker: Mr J. Caro Codon (Madrid, ES)

Thumbnail

Access the full session

Cardio-oncology

Speakers: Doctor L. Michel, Mr J. Leerink, Doctor V. Quagliariello, Doctor H. Mustafic, Doctor V. Quagliariello...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk